This glue is made from leftover cooking oil, which contains fatty acids that are ideal for making flexible, durable, and ...

The committee for the Contemporary Era Hall of Fame ballot meets this coming weekend at MLB's Winter Meetings. From this group, we'll likely see at least one new member of the Hall of Fame. It won't ...

A new scientific review suggests that mushrooms may offer more than just low-calorie nutrition. A group of authors analyzed human studies to see whether eating mushrooms could improve markers of heart ...

Plozasiran is the first FDA-approved drug for familial chylomicronemia syndrome, reducing triglycerides as an adjunct to diet. The phase 3 PALISADE trial showed significant triglyceride reduction with ...

NEW ORLEANS — When added to standard lipid-lowering therapy, olezarsen, a drug approved in 2024 for patients with familial chylomicronemia syndrome, significantly lowered triglycerides and reduced the ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn LDL cholesterol and triglycerides in patients whose levels refused to budge ...

NEW ORLEANS -- An investigational triple-receptor agonist made some headway in patients with severe hypertriglyceridemia, a phase II study showed. One Chinese cohort had triglycerides slashed from ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. People with severe hypertriglyceridemia, defined as ...

Please provide your email address to receive an email when new articles are posted on . Olezarsen reduced triglycerides and the rate of acute pancreatitis events in patients with severely elevated ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Ionis Pharmaceuticals reported on Tuesday that a drug approved for a rare disease ...

Olezarsen decreased levels of triglycerides compared with placebo in patients with moderate hypertriglyceridemia and elevated cardiovascular risk, according to a late-breaking trial presented in a Hot ...